Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre

Nephrology Dialysis Transplantation

Volumn 14, Issue 11, 1999, Pages 2692-2697

  Desassis, Jean François ^a,c   Laperche, Syria ^b   Girault, Annie ^b   Kolko, Anne ^a   Bouchardeau, Françoise ^b   Zins, Brigitte ^a   Poignet, Jean Louis ^a   Couroucé, Anne Marie ^b  

^a Edouard Rist Medical Center   (France)

^b INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^c Dept Pharmacy   (France)

Author keywords

Anti E2 antibodies; GBV C HGV; Haemodialysis; HCV; PCR

Indexed keywords

ALANINE AMINOTRANSFERASE; PROTEIN ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD EXAMINATION; CONTAMINATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; FRANCE; HEMODIALYSIS PATIENT; HEPATITIS; HEPATITIS B; HEPATITIS C; HEPATITIS G VIRUS; HEPATITIS GB VIRUS B; HIGH RISK PATIENT; HOSPITAL; HUMAN; HUMAN TISSUE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SERUM; STATISTICS; VIREMIA; VIRUS DETECTION;

EID: 0033281535     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.11.2692     Document Type: Article

References (36)

1. Isolation of novel virus-like sequences associated with human hepatitis
2. Molecular cloning and disease association of Hepatitis G virus: A transfusion-transmissible agent
3. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease
4. Infection with hepatitis GB virus C in patients on maintenance hemodialysis
5. Natural history of GBV-C/hepatitis G virus infection through the follow-up of GBV-C/hepatitis G virus-infected blood donors and recipients studied by RNA polymerase chain reaction and anti-E2 serology
6. Hepatitis C and G virus infection and liver dysfunction after allogenic bone marrow transplantation results from a prospective study
7. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients
8. GBV-C/HGV: A new virus within the Flaviviridae and its clinical implication
9. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: High prevalence of HGV infection and spontaneous remission
10. Hepatitis G virus infection in haemodialysed patients: Epidemiology and clinical relevance
11. Hepatitis G virus infection in a haemodialysis unit: Prevalence and clinical implications
12. Hepatitis G virus infection in hemodialysis patients
13. Hepatitis GB virus C in patients on hemodialysis
14. GBVC/HGV infection in renal dialysis and transplant patients
15. GBV-C/HGV in hemodialysis patients: Anti-E2 antibodies and GBV-C/RNA in serum and peripheral blood mononuclear cells
16. Clinical impact of GB-C virus in haemodialysis patients
17. High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis
18. Prevalence of hepatitis G virus RNA and antibodies in French blood donors: Results of a collaborative study
19. Prevalence of hepatitis G virus RNA in French blood donors and recipients
20. Acute non A-E hepatitis in the United States and the role of hepatitis G virus infection
21. Current status of hepatitis G virus (GBV-C) in transfusion: Is it relevant?
22. Fulminant hepatitis and new G/GB V-C flavivirus
23. Hepatitis G virus in immunosuppressed paediatric allograft recipients
24. Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients
25. An ELISA for detection of antibodies to the E2 protein of GB virus C
26. Detection of antibodies to a putative hepatitis G virus envelope protein
27. Expression of the GB virus C E2 glycoprotein using the Semikli Forest virus vector system and its utility as a serologic marker
28. Association of antibody to GB virus c (hepatitis G virus) with viral clearance and protection from reinfection
29. Significance of antibodies to recombinant E2 protein of hepatitis G virus in haemodialysis patients
30. Multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum
31. Prevalence of HIV infection in dialysis patients. A French cooperative study
32. Does HCV screening of blood donors affect transmission of hepatitis G Virus in dialysed patients?
33. Detection of the GBV-C hepatitis virus genome in patients with fulminant hepatitis of unknown aetiology
34. Aplastic anaemia after HGV infection
35. Hepatitis G-associated aplastic anaemia
36. Hepatitis G virus-a true hepatitis virus or an accidental tourist